Studio Investment Management’s Dimensional International Core Equity Market ETF DFAI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$828K Buy
20,077
+4,321
+27% +$178K 0.14% 96
2026
Q1
$614K Buy
15,756
+339
+2% +$13.6K 0.11% 107
2025
Q4
$588K Sell
15,417
-226
-1% -$8.38K 0.11% 114
2025
Q3
$569K Buy
15,643
+230
+1% +$8.13K 0.11% 114
2025
Q2
$533K Buy
15,413
+522
+4% +$17.1K 0.11% 115
2025
Q1
$465K Buy
14,891
+282
+2% +$8.71K 0.1% 123
2024
Q4
$427K Buy
14,609
+1,724
+13% +$52.3K 0.09% 115
2024
Q3
$409K Buy
12,885
+4,902
+61% +$150K 0.09% 126
2024
Q2
$237K Buy
7,983
+2,248
+39% +$67.5K 0.05% 149
2024
Q1
$173K Buy
5,735
+1,701
+42% +$49.3K 0.04% 159
2023
Q4
$116K Buy
+4,034
New +$108K 0.03% 161

Other funds holding DFAI

Studio Investment Management's DFAI Position: Q2 2026 in Review

Studio Investment Management increased its Dimensional International Core Equity Market ETF (DFAI) stake by 27% in Q2 2026, buying an estimated $178K and bringing the position to 20,077 shares worth $828K. The position accounts for 0.14% of the portfolio, ranked #96.

Studio Investment Management first reported a position in DFAI in Q4 2023 and has held it in 11 quarters since. 831 funds tracked by Wall St. Rank hold DFAI as of Q2 2026.

  • Studio Investment Management held 20,077 shares of Dimensional International Core Equity Market ETF worth $828K as of Q2 2026.
  • Studio Investment Management bought 4,321 Dimensional International Core Equity Market ETF shares in Q2 2026, an estimated $178K.
  • Dimensional International Core Equity Market ETF made up 0.14% of Studio Investment Management's portfolio in Q2 2026, its #96 holding.
  • Studio Investment Management first reported a position in Dimensional International Core Equity Market ETF in Q4 2023 and has held it in 11 quarters since.
  • 831 funds tracked by Wall St. Rank held Dimensional International Core Equity Market ETF as of Q2 2026.

Based on Studio Investment Management's 13F filing for Q2 2026, filed 31 Jul 2026.